1. 1) Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev., 15, 788–830 (1994).
2. 2) Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002). Thyroid, 17, 1211–1223 (2007).
3. 3) Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab., 87, 489–499 (2002).
4. 4) Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N. Engl. J. Med., 316, 764–770 (1987).
5. 5) Kurayoshi K, Kimura O, Toyoda N, Sakamoto H, Siota S, Yonekawa M, Hoshino K, Maeta M, Kaibara N. Report of a case with transrectal administration of thyroid hormone after total esophagectomy combined with trhyroidectomy, parathyroidectomy and pharyngo-laryngectomy for cervical esophageal cancer. Nihon Shokaki Geka Gakkai Zasshi, 24, 856–860 (1991).